QuidelOrtho (QDEL) Net Income towards Common Stockholders (2021 - 2026)
QuidelOrtho (QDEL) posted Net Income towards Common Stockholders of $700000.0 for Q1 2026, up 177.78% sequentially from -$900000.0 in Q4 2025, and up 118.92% YoY from $319753.1 in Q1 2025.
QuidelOrtho (QDEL) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
QuidelOrtho has reported Net Income towards Common Stockholders for 6 years, with the latest figure at $700000.0 in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 118.92% year-over-year to $700000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.7 million (up 67.32% YoY) and the FY2025 annual result came in at -$11.1 million, up 99.46% from the prior year.
- Net Income towards Common Stockholders improved to $700000.0 in Q1 2026 per QDEL's latest filing, from -$900000.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $479.9 million in Q2 2022 and troughed at -$1.7 billion in Q1 2024.
- A 5-year average of -$97.0 million and a median of -$3.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2026: Net Income towards Common Stockholders slumped 3607.99% in 2024, then surged 118.92% in 2026.
- Over 5 years, Net Income towards Common Stockholders stood at $19.2 million in 2022, then slumped by 2892.19% to -$536.1 million in 2023, then jumped by 99.29% to -$3.8 million in 2024, then jumped by 76.32% to -$900000.0 in 2025, then jumped by 177.78% to $700000.0 in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $700000.0, -$900000.0, and -$2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | QuidelOrtho | 985.30 Mn | 861.90 Mn | - | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 1.50 Mn |
| Mar 29, 2026 | 700,000.00 |
| Dec 28, 2025 | -900,000.00 |
| Sep 28, 2025 | -2.90 Mn |
| Jun 29, 2025 | -3.60 Mn |
| Mar 30, 2025 | -3.70 Mn |
| Dec 29, 2024 | -3.80 Mn |
| Sep 29, 2024 | -6.80 Mn |
| Jun 30, 2024 | -6.20 Mn |
| Mar 31, 2024 | -1.71 Bn |
| Dec 31, 2023 | -536.10 Mn |
| Oct 1, 2023 | -19.00 Mn |
| Jul 2, 2023 | -57.50 Mn |
| Apr 2, 2023 | 48.80 Mn |
| Jan 1, 2023 | 135.80 Mn |
| Oct 2, 2022 | 19.20 Mn |
| Jul 3, 2022 | 19.30 Mn |
| Apr 3, 2022 | 479.90 Mn |
| Oct 3, 2021 | 215.70 Mn |
| Jul 4, 2021 | 19.10 Mn |